Overview

Beta-blockers for Oesophageal Varices

Status:
Recruiting
Trial end date:
2024-12-01
Target enrollment:
Participant gender:
Summary
To determine if carvedilol reduces the rate of variceal haemorrhage in patients with cirrhosis and small oesophageal varices
Phase:
Phase 4
Details
Lead Sponsor:
King's College Hospital NHS Trust
Collaborators:
Brighton and Sussex University Hospitals NHS Trust
Cardiff University
Guy's and St Thomas' NHS Foundation Trust
King's College London
St George's University Hospitals NHS Foundation Trust
Treatments:
Adrenergic beta-Antagonists
Carvedilol